Application Information

This drug has been submitted to the FDA under the reference 076173/001.

Names and composition

"RILUZOLE" is the commercial name of a drug composed of RILUZOLE.
It belongs to the class Amyotrophic lateral sclerosis treatments and is used in ALS, Huntington's disease, amyloid neuropathy (Central Nervous System)

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
076173/001 RILUZOLE RILUZOLE TABLET/ORAL 50MG
091300/001 RILUZOLE RILUZOLE TABLET/ORAL 50MG
091394/001 RILUZOLE RILUZOLE TABLET/ORAL 50MG
091417/001 RILUZOLE RILUZOLE TABLET/ORAL 50MG
203042/001 RILUZOLE RILUZOLE TABLET/ORAL 50MG
204048/001 RILUZOLE RILUZOLE TABLET/ORAL 50MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
020599/001 RILUTEK RILUZOLE TABLET/ORAL 50MG
076173/001 RILUZOLE RILUZOLE TABLET/ORAL 50MG
091300/001 RILUZOLE RILUZOLE TABLET/ORAL 50MG
091394/001 RILUZOLE RILUZOLE TABLET/ORAL 50MG
091417/001 RILUZOLE RILUZOLE TABLET/ORAL 50MG
203042/001 RILUZOLE RILUZOLE TABLET/ORAL 50MG
204048/001 RILUZOLE RILUZOLE TABLET/ORAL 50MG

Manufacturers

Manufacturer name
Sanofi
Martindale Pharmaceuticals

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved